Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2017, Article ID 5762525, 3 pages
https://doi.org/10.1155/2017/5762525
Case Report

Severe Cytomegalovirus Reactivation in Patient with Low-Grade Non-Hodgkin’s Lymphoma after Standard Chemotherapy

Department of Haematology, Warwick Hospital, Warwick, UK

Correspondence should be addressed to Lena Modvig; moc.kooltuo@givdomanel

Received 28 April 2017; Revised 29 September 2017; Accepted 9 October 2017; Published 22 October 2017

Academic Editor: Sergio Storti

Copyright © 2017 Lena Modvig et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. S. Azevedo, L. C. Pierrotti, E. Abdala et al., “Cytomegalovirus infection in transplant recipients,” Clinics, vol. 70, no. 7, pp. 515–523, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. R. B. Effros, “The silent war of CMV in aging and HIV infection,” Mechanisms of Ageing and Development, vol. 158, pp. 46–52, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. A. B. Fassas, J. Bolanos-Meade, L. N. Buddharaju et al., “Cytomegalovirus infection and non-neutropenic fever after autologous stem cell transplantation: high rates of reactivation in patients with multiple myeloma and lymphoma,” British Journal of Haematology, vol. 112, no. 1, pp. 237–241, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Heininger, G. Jahn, C. Engel, T. Notheisen, K. Unertl, and K. Hamprecht, “Human cytomegalovirus infections in nonimmunosuppressed critically ill patients,” Critical Care Medicine, vol. 29, no. 3, pp. 541–547, 2001. View at Publisher · View at Google Scholar
  5. S. Jaber, G. Chanques, J. Borry et al., “Cytomegalovirus infection in critically ill patients: associated factors and consequences,” Chest, vol. 127, no. 1, pp. 233–241, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Osawa and N. Singh, “Cytomegalovirus infection in critically ill patients: a systematic review,” Critical Care, vol. 13, no. 3, p. R68, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Gafter-Gvili and A. Polliack, “Bendamustine associated immune suppression and infections during therapy of hematological malignancies,” Leukemia & Lymphoma, vol. 57, no. 3, pp. 512–519, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Hosoda, A. Yokoyama, M. Yoneda et al., “Bendamustine can severely impair T-cell immunity against cytomegalovirus,” Leukemia & Lymphoma, vol. 54, no. 6, pp. 1327-1328, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Gafter-Gvili, E. Ribakovsky, N. Mizrahi et al., “Infections associated with bendamustine containing regimens in hematological patients: a retrospective multi-center study,” Leukemia & Lymphoma, vol. 57, no. 1, pp. 63–69, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Saito, D. Maruyama, A. M. Maeshima et al., “Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma,” Blood Cancer Journal, vol. 5, no. 10, p. e362, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. B. S. Kahl, N. L. Bartlett, J. P. Leonard et al., “Bendamustine is effective therapy in patients with rituximab-refractory, indolent B-cell non-Hodgkin lymphoma: results from a multicenter study,” Cancer, vol. 116, no. 1, pp. 106–114, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. S. H. Lim, S. Pathapati, J. Langevin, and A. Hoot, “Severe CMV reactivation and gastritis during treatment of follicular lymphoma with bendamustine,” Annals of Hematology, vol. 91, no. 4, pp. 643-644, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Nomura, Y. Kamitsuji, E. Kono et al., “Severe cytomegalovirus enterocolitis after standard chemotherapy for non-Hodgkin’s lymphoma,” Scandinavian Journal of Gastroenterology, vol. 40, no. 5, pp. 604–606, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Polprasert, C. Wongjitrat, and N. Wisedopas, “Case report: severe CMV colitis in a patient with follicular lymphoma after chemotherapy,” Journal of the Medical Association of Thailand, vol. 94, no. 4, pp. 498–500, 2011. View at Google Scholar
  15. R. R. Razonable, A. Asberg, H. Rollag et al., “Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the World Health Organization International Standard is predictive of CMV disease resolution in transplant recipients,” Clinical Infectious Disease, vol. 56, no. 11, pp. 1546–1553, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Perrottet, O. Manuel, F. Lamoth et al., “Variable viral clearance despite adequate ganciclovir plasma levels during valganciclovir treatment for cytomegalovirus disease in D+/R− transplant recipients,” BMC Infectious Disease, vol. 10, no. 1, p. 2, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. C. F. Thomas Jr. and A. H. Limper, “Pneumocystis pneumonia,” New England Journal of Medicine, vol. 350, no. 24, pp. 2487–2498, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Goto, K. Futamura, M. Okada et al., “Management of Pneumocystis jirovecii pneumonia in kidney transplantation to prevent further outbreak,” Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine, vol. 9, no. 1, pp. 81–90, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Fillatre, O. Decaux, S. Jouneau et al., “Incidence of Pneumocystis jiroveci pneumonia among groups at risk in HIV-negative patients,” American Journal of Medicine, vol. 127, no. 12, pp. 1242.e11–1242.e17, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. T. P. Charles and J. E. Shellito, “Human immunodeficiency virus infection and host defense in the lungs,” Seminars in Respiratory and Critical Care Medicine, vol. 37, no. 2, pp. 147–156, 2016. View at Publisher · View at Google Scholar · View at Scopus